Seth Klarman: portfolio of Baupost Group

Seth Klarman leads the Baupost Group, which follows a value approach and looks for securities trading below their estimated worth.

Source: 13F filing with the US Securities and Exchange Commission dated Feb 11, 2022. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q4 2021. Go to the latest filing (Q3 2026)

10.1B USDQ4 2021
Total value of stock positions
10.1B USD
Positions
53
Share of the ten largest
66.3%

The ten largest positions Q4 2021

  1. Liberty Global PLC 15.0%unchanged
  2. Qorvo Inc 9.2%▲ +16.9%
  3. Intel 9.2%▼ −8.7%
  4. Viasat Inc 7.2%unchanged
  5. Alphabet Inc. (Class C) 6.5%▼ −21.6%
  6. Liberty Media Corp Del 5.3%▲ +15.7%
  7. Veritiv Corp 4.3%unchanged
  8. Meta Platforms 3.3%▼ −36.4%
  9. Fiserv 3.1%new
  10. SS&C Technologies HLDGS Inc 3.1%unchanged
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 12.7B USD).
Choose a quarter (54 filings)

All positions Q4 2021

Positions Q4 2021 per 13F filing, 5 of 5
Symbol Weight Shares Reported value Change Held since
Qorvo Inc 9.2% 5,945,744 929.9M USD +16.9% increased Q1 2017 20 quarters
Liberty Media Corp Del 5.3% 10,509,867 534.4M USD +15.7% increased Q1 2020 8 quarters
WTW Willis Towers Watson 2.9% 1,250,000 296.9M USD +25.0% increased Q1 2021 4 quarters
Liberty Media Corp Del 2.5% 4,975,000 253.0M USD +13.1% increased Q3 2020 6 quarters
Verint Sys Inc 2.0% 3,754,965 197.2M USD +6.4% increased Q2 2020 7 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Plus 1 position in convertible bonds and bonds worth 28.8M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Theravance Biopharma Inc principal 30.0M USD 28.8M USD

Breakdown by sector

  • Technology 13.7%
  • Communication Services 9.8%
  • Financials 6.1%
  • Industrials 0.7%
  • not in our coverage 69.7%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close